ProNephro AKI (NGAL) is now commercially available.

Investor Contacts

Other Ways to Connect

To receive investor announcements, please subscribe below.

Investor Relations

Niels Høy Nielsen, BioPorto A/S

BioPorto A/S Headquarters

Tuborg Havnevej 15
2900 Hellerup
Denmark

Contact Investor Relations